![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiyt4ld1R0v1vzaL3nQo58HV_LVeQ0jwwTwmXDJSc1InCHJ0laNUMvNqm_SiUFiO_AJ88Sknql_LoH_gyF6uutn4Ayuc5yzitRie-j1Asl2qJf0si-PZpDWuCEzbnEfhe8dGkpsPVPTBtwq/s320/ucm162880.gif)
![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiUFGiJ5_sQD0lydfZHo5O1qBHQU39dxhh98-CdlrMmXWW8VLSAGhLNKlct0a_a1_UthqjNX0N_pWiuWcE3VMW04b0AB8KbkQZWhCRTCZGGSUjj2g-ntjHw42Hi2P5vjdQG6I-mP1iHmroL/s320/ucm052224.gif)
The MedWatch January 2010 Drug Safety Labeling Changes posting includes 36 drug products with safety labeling changes to the following sections: BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, PATIENT PACKAGE INSERT, and MEDICATION GUIDE.
The "Summary Page" provides a listing of drug names and safety labeling sections revised:
http://www.fda.gov/Safety/MedWatch/SafetyInformation/ucm200254.htm
Clicking on a drug product name in the Summary View will take you to the "detailed view" page, which identifies safety labeling sections and subsections revised, along with a brief summary of new or modified safety information to the BOXED WARNING, CONTRAINDICATIONS, and/or WARNINGS sections.
The following drugs had modifications to the BOXED WARNING, CONTRAINDICATIONS, and WARNINGS sections:
Exjade (deferasirox)
Aristocort Forte (triamcinolone diacetate)
Boniva (ibandronate sodium)
Effexor (venlafaxine HCl)
Invirase (saquinavir mesylate)
Kaletra (lopinavir/ritonavir)
RotaTeq (rotavirus vaccine, live, pentavalent)
Tykerb (lapatinib)
Cancidas (caspofungin acetate)
Cardene (nicardipine hydrochloride)
Coumadin (warfarin sodium)
Crestor (rosuvastatin calcium)
Kenalog (triamcinolone acetonide)
Pexeva (paroxetine mesylate)
R-Gene 10 (arginine hydrochloride)
Remodulin (treprostinil)
Symbyax (olanzapine and fluoxetine hydrochloride)
Toprol-XL (metoprolol succinate)
Videx EC (didanosine)
Viramune (nevirapine)
Zyprexa (olanzapine)
No hay comentarios:
Publicar un comentario